Angiocrine Bioscience
Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.
Org chart
Teams
View all
Discover similar companies
BioMarin Pharmaceutical
Post IPO Debt • San Rafael, United States
Regeneron
Post IPO Equity • Tarrytown, United States
Verve Therapeutics
Series B • Cambridge, United States
Biogen
Cambridge, United States
Imvax
Series C • Philadelphia, United States
Guardant Health
Venture • Redwood City, United States
Genentech
Venture • South San Francisco, United States
Zymo Research
Irvine, United States
Embark Veterinary
Series B • Boston, United States
Culture Biosciences
Series B • South San Francisco, United States
Celsius Therapeutics
Series B • Cambridge, United States
ARCA biopharma
Westminster, United States
helps you hire
great candidates
It’s free to use - try it out today.